Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
暂无分享,去创建一个
Ping Wang | Lujun Zhao | Linlin Gong | Zhiyan Liu | Ping Wang | Lujun Zhao | Zhiyan Liu | Zhiyong Yuan | Jing Wang | Baozhong Zhang | L. Gong | Jing Wang | Baozhong Zhang | Z. Yuan
[1] B. Movsas,et al. Thoracic radiotherapy for limited stage small cell lung carcinoma. , 2012, Current problems in cancer.
[2] Jeffrey D Bradley,et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. , 2013, International journal of radiation oncology, biology, physics.
[3] J. M. Taylor,et al. Dose-response relationship for radiation therapy of subclinical disease. , 1995, International journal of radiation oncology, biology, physics.
[4] Benjamin Movsas,et al. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. , 2005, International journal of radiation oncology, biology, physics.
[5] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[6] P. Warde,et al. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] W. Curran,et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.
[8] J P Pignon,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.
[9] Joe Y. Chang,et al. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.
[10] K. Kiel,et al. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy. , 2014, Practical radiation oncology.
[11] A. Bezjak,et al. CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). , 2016 .
[12] E. Yorke,et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Hillman,et al. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Rudin,et al. Management of small-cell lung cancer: incremental changes but hope for the future. , 2008, Oncology.
[15] D. Ettinger,et al. Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. , 2012, International journal of radiation oncology, biology, physics.
[16] R. Arusell,et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.